1-2 of 2
Rémi Gressin
Close
Sort by
Journal Articles

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Clinical Trials & Observations
Emmanuel Gyan, Charles Foussard, Philippe Bertrand, Patrick Michenet, Steven Le Gouill, Christian Berthou, Hervé Maisonneuve, Vincent Delwail, Rémi Gressin, Philippe Quittet, Jean-Pierre Vilque, Bernard Desablens, Jérôme Jaubert, Jean-François Ramée, Nina Arakelyan, Antoine Thyss, Cécile Moluçon-Chabrot, Roselyne Delépine, Noël Milpied, Philippe Colombat, Eric Deconinck
Journal: Blood
Blood (2009) 113 (5): 995–1001.
https://doi.org/10.1182/blood-2008-05-160200
Published: 2009
Journal Articles

Rituximab Given after High Dose Therapy and Autologous Stem Cell Transplantation Induces Durable Clearance of Minimal Residual Disease in about Half of the Patients with Follicular Non Hodgkin’s Lymphoma : 36 Months Results of a Multicenter Open Label Phase II Trial (M39012 Trial).

Franck Morschhauser, Christian Recher, Noel Milpied, Remi Gressin, Gilles Salles, Pauline Brice, Norbert Vey, Corinne Haioun, Philippe Colombat, Jean-Henri Bourhis, Jean-Francois Rossi, Nathalie Berriot-Varoqueaux, Loic Bergougnoux, Andre Bosly, Georges Delsol, Michel Attal
Journal: Blood
Blood (2004) 104 (11): 747.
https://doi.org/10.1182/blood.V104.11.747.747
Published: 2004